Article Details

Prime Medicine, Inc. (NYSE:PRME) Receives $12.67 Consensus Price Target from Analysts

Retrieved on: 2024-12-14 18:08:10

Tags for this article:

Click the tags to see associated articles and topics

Prime Medicine, Inc. (NYSE:PRME) Receives $12.67 Consensus Price Target from Analysts. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 1,330,927 shares of the company's stock valued at $6,841,000 after purchasing an additional 895,610 shares during ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo